Results for tag: "GABAA Modulator"

The GABAA Modulator market is a subset of the Central Nervous System Drugs market. It is composed of drugs that act on the GABAA receptor, a type of neurotransmitter receptor found in the brain. These drugs are used to treat a variety of neurological disorders, including anxiety, insomnia, epilepsy, and depression. GABAA Modulators are typically divided into two categories: benzodiazepines and non-benzodiazepines. Benzodiazepines are the most commonly prescribed GABAA Modulators, while non-benzodiazepines are used for more severe cases. Some companies in the GABAA Modulator market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Other companies include Sanofi, AstraZeneca, and Johnson & Johnson. Show Less Read more